As of 2025-07-15, the EV/EBITDA ratio of Homology Medicines Inc (FIXX) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FIXX's latest enterprise value is -6.57 mil USD. FIXX's TTM EBITDA according to its financial statements is -92.11 mil USD. Dividing these 2 quantities gives us the above FIXX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 13.4x | 10.8x |
| Forward P/E multiples | 12.4x - 20.6x | 16.5x |
| Fair Price | (828.25) - (897.42) | (914.72) |
| Upside | -3473.7% - -3755.5% | -3825.9% |
| Date | EV/EBITDA |